Artificial Intelligence Enables Whole-body Positron Emission Tomography Scans with Minimal Radiation Exposure
Overview
Nuclear Medicine
Radiology
Authors
Affiliations
Purpose: To generate diagnostic F-FDG PET images of pediatric cancer patients from ultra-low-dose F-FDG PET input images, using a novel artificial intelligence (AI) algorithm.
Methods: We used whole-body F-FDG-PET/MRI scans of 33 children and young adults with lymphoma (3-30 years) to develop a convolutional neural network (CNN), which combines inputs from simulated 6.25% ultra-low-dose F-FDG PET scans and simultaneously acquired MRI scans to produce a standard-dose F-FDG PET scan. The image quality of ultra-low-dose PET scans, AI-augmented PET scans, and clinical standard PET scans was evaluated by traditional metrics in computer vision and by expert radiologists and nuclear medicine physicians, using Wilcoxon signed-rank tests and weighted kappa statistics.
Results: The peak signal-to-noise ratio and structural similarity index were significantly higher, and the normalized root-mean-square error was significantly lower on the AI-reconstructed PET images compared to simulated 6.25% dose images (p < 0.001). Compared to the ground-truth standard-dose PET, SUV values of tumors and reference tissues were significantly higher on the simulated 6.25% ultra-low-dose PET scans as a result of image noise. After the CNN augmentation, the SUV values were recovered to values similar to the standard-dose PET. Quantitative measures of the readers' diagnostic confidence demonstrated significantly higher agreement between standard clinical scans and AI-reconstructed PET scans (kappa = 0.942) than 6.25% dose scans (kappa = 0.650).
Conclusions: Our CNN model could generate simulated clinical standard F-FDG PET images from ultra-low-dose inputs, while maintaining clinically relevant information in terms of diagnostic accuracy and quantitative SUV measurements.
Diffused Multi-scale Generative Adversarial Network for low-dose PET images reconstruction.
Yu X, Hu D, Yao Q, Fu Y, Zhong Y, Wang J Biomed Eng Online. 2025; 24(1):16.
PMID: 39924498 PMC: 11807330. DOI: 10.1186/s12938-025-01348-x.
Kanavos T, Birbas E, Zanos T Cancers (Basel). 2025; 17(1.
PMID: 39796698 PMC: 11719749. DOI: 10.3390/cancers17010069.
Montgomery M, Andersen F, Mathiasen R, Borgwardt L, Andersen K, Ladefoged C Diagnostics (Basel). 2025; 14(24.
PMID: 39767149 PMC: 11727418. DOI: 10.3390/diagnostics14242788.
Peng Z, Zhang F, Jiang H, Liu G, Sun J, Du Y Quant Imaging Med Surg. 2024; 14(12):8140-8154.
PMID: 39698633 PMC: 11652058. DOI: 10.21037/qims-24-489.
Csikos C, Barna S, Kovacs A, Czina P, Budai A, Szolikova M Diagnostics (Basel). 2024; 14(23).
PMID: 39682594 PMC: 11640603. DOI: 10.3390/diagnostics14232686.